What do systematic reviews say?

One type of repeat midurethral tape vs another type of repeat midurethral tape

The review found no eligible studies for this question.

• Interventions for treating recurrent stress urinary incontinence after failed minimally invasive synthetic midurethral… 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Artificial urinary sphincter implantation vs endourethral Macroplastique injection

It is very uncertain whether artificial urinary sphincter implantation changes success rate ‐ dry compared with endourethral Macroplastique injection (very low certainty).

• Surgery for stress urinary incontinence due to presumed sphincter deficiency after prostate surgery 2014 · Cochrane Headline outcomes only
  OR 5.67 [1.28, 25.1]
  1 study · 45 participants
  Very low

Artificial urinary sphincter implantation vs endourethral Macroplastique injection

• Surgery for stress urinary incontinence due to presumed sphincter deficiency after prostate surgery 2014 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 45 participants
  Very low

Oestrogen therapy alone vs surgery

The review found no eligible studies for this question.

• Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Oestrogen therapy alone vs surgery

The review found no eligible studies for this question.

• Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Oestrogen therapy alone vs surgery

The review found no eligible studies for this question.

• Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Oestrogen therapy alone vs surgery

The review found no eligible studies for this question.

• Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Oestrogen therapy alone vs surgery

The review found no eligible studies for this question.

• Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Oestrogen therapy alone vs surgery

The review found no eligible studies for this question.

• Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Oestrogen therapy alone vs surgery

The review found no eligible studies for this question.

• Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intermittent self‐dilatation vs no treatment

It is very uncertain whether intermittent self‐dilatation changes recurrent urethral stricture compared with no treatment (very low certainty).

• Intermittent self‐dilatation for urethral stricture disease in males 2014 · Cochrane Headline outcomes only
  RR 0.7 [0.48, 1]
  6 studies · 404 participants
  Very low

Vaginal procedure vs sacral colpopexy (vault prolapse)

Vaginal procedure probably leads to higher awareness of prolapse compared with sacral colpopexy (vault prolapse) (moderate certainty).

• Surgery for women with apical vaginal prolapse 2023 · Cochrane Headline outcomes only
  RR 2.31 [1.27, 4.21]
  4 studies · 346 participants
  Moderate

Vaginal hysterectomy vs sacral hysteropexy/cervicopexy (uterine prolapse)

Vaginal hysterectomy showed no clear difference in prolapse on examination (Stage 2 or greater) ‐ Any recurrent prolapse compared with sacral hysteropexy/cervicopexy (uterine prolapse) (moderate certainty).

• Surgery for women with apical vaginal prolapse 2023 · Cochrane Headline outcomes only
  RR 0.78 [0.54, 1.11]
  2 studies · 230 participants
  Moderate

Vaginal hysterectomy vs sacral hysteropexy/cervicopexy (uterine prolapse)

It is very uncertain whether vaginal hysterectomy changes mesh exposure compared with sacral hysteropexy/cervicopexy (uterine prolapse) (very low certainty).

• Surgery for women with apical vaginal prolapse 2023 · Cochrane Headline outcomes only
  RR 1.85 [0.7, 4.87]
  4 studies · 307 participants
  Very low

Vaginal hysterectomy vs sacral hysteropexy/cervicopexy (uterine prolapse)

• Surgery for women with apical vaginal prolapse 2023 · Cochrane Headline outcomes only
  no estimate extracted
  5 studies · 422 participants
  Low

Vaginal hysterectomy vs sacral hysteropexy/cervicopexy (uterine prolapse)

• Surgery for women with apical vaginal prolapse 2023 · Cochrane Headline outcomes only
  no estimate extracted
  5 studies · 422 participants
  Very low

Vaginal hysterectomy vs sacral hysteropexy/cervicopexy (uterine prolapse)

• Surgery for women with apical vaginal prolapse 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 148 participants
  Low

Vaginal hysteropexy vs sacral hysteropexy (uterine prolapse)

Vaginal hysteropexy showed no clear difference in awareness of prolapse compared with sacral hysteropexy (uterine prolapse) (low certainty).

• Surgery for women with apical vaginal prolapse 2023 · Cochrane Headline outcomes only
  RR 0.55 [0.21, 1.44]
  1 study · 257 participants
  Low

Vaginal hysteropexy vs sacral hysteropexy (uterine prolapse)

Vaginal hysteropexy showed no clear difference in prolapse on examination (Stage 2 or above) ‐ Any recurrent prolapse compared with sacral hysteropexy (uterine prolapse) (moderate certainty).

• Surgery for women with apical vaginal prolapse 2023 · Cochrane Headline outcomes only
  RR 0.99 [0.83, 1.19]
  2 studies · 367 participants
  Moderate

Vaginal hysteropexy vs sacral hysteropexy (uterine prolapse)

It is very uncertain whether vaginal hysteropexy changes mesh exposure (1‐4 years) compared with sacral hysteropexy (uterine prolapse) (very low certainty).

• Surgery for women with apical vaginal prolapse 2023 · Cochrane Headline outcomes only
  RR 7.05 [0.37, 135.2]
  1 study · 257 participants
  Very low